Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.
Nat Commun. 2023 Oct 24;14(1):6761. doi: 10.1038/s41467-023-42400-5.
Nat Commun. 2023.
PMID: 37875494
Free PMC article.
Clinical Trial.
Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown Primary.
Pouyiourou M, Bochtler T, Coith C, Wikman H, Kraft B, Hielscher T, Stenzinger A, Riethdorf S, Pantel K, Krämer A.
Pouyiourou M, et al.
Clin Chem. 2024 Jan 4;70(1):297-306. doi: 10.1093/clinchem/hvad180.
Clin Chem. 2024.
PMID: 38175594
Item in Clipboard
Human SLFN5 and its Xenopus Laevis ortholog regulate entry into mitosis and oocyte meiotic resumption.
Vit G, Hirth A, Neugebauer N, Kraft BN, Sigismondo G, Cazzola A, Tessmer C, Duro J, Krijgsveld J, Hofmann I, Berger M, Klüter H, Niehrs C, Nilsson J, Krämer A.
Vit G, et al. Among authors: kraft bn.
Cell Death Discov. 2022 Dec 8;8(1):484. doi: 10.1038/s41420-022-01274-0.
Cell Death Discov. 2022.
PMID: 36477080
Free PMC article.
Item in Clipboard
Cite
Cite